Learn More
Medchemexpress LLC Quizartinib | 950769-58-1 | 99.1% | 200 MG

Supplier: Medchemexpress LLC HY13001200MG
Quizartinib is an orally active, highly selective, and potent second-generation type II FLT3 tyrosine kinase inhibitor. It inhibits wild-type FLT3 and FLT3-ITD autophosphorylation in MV4-11 cells, with IC50s of 4.2 nM and 1.1 nM respectively. This compound can be linked to the VHL ligand via an optimized linker to form a PROTAC FLT3 degrader, and it induces apoptosis. It is intended for research use only.
- Orally active
- Highly selective and potent type II FLT3 tyrosine kinase inhibitor
- Inhibits wild-type FLT3 and FLT3-ITD autophosphorylation
- Forms PROTAC FLT3 degrader when linked to VHL ligand
- Induces apoptosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.